The effectiveness of Fluticasone furoate for pediatric allergic rhinitis patients with nasal obstruction and sleep disturbance.

The effectiveness of Fluticasone furoate for pediatric allergic rhinitis patients with nasal obstruction and sleep disturbance. - The effectiveness of Fluticasone furoate for pediatric allergic rhinitis patients with nasal obstruction and sleep disturbance.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011740

Enrollment

Registered

2013-09-12

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis, sleep disturbance

Interventions

1)washout 2)Fluticasone furoate 27.5ug spray each nasalcavity once/day 4 weeks 3)evaluate on within 3 days after final medication

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: diagnosed as a sleep distuabance within one month before trial

Exclusion criteria

Exclusion criteria: 1)patient who need oral steroid intake 2)hypersensitivity for Fluticasone furoate 3)The patient who is judged as inappropriate for the study by doctor 4)infectious disease without effective antibiotics, patient of the deep seated mycosis

Design outcomes

Primary

Measure	Time frame
OSA18	—

Secondary

Measure	Time frame
Children's Sleep Habit Questionnaire Japan (CSHQ-J) sleep study rhinoscopic findings score	—

Countries

Japan

Contacts

Public ContactHirotaka Hara

Yamaguchi University Graduate School of Medicine Department of Otolaryngology

harahiro@yamaguchi-u.ac.jp0836-22-2281

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026